Factors Associated with HIV Status Disclosure and Its Effect on Treatment Adherence and Quality of Life among Children 6–17 Years on Antiretroviral Therapy in Southern Highlands Zone, Tanzania: Unmatched Case Control Study

Table 6

Relationship between HIV status disclosure and quality of life, among children between 6 and 17 years on antiretroviral therapy, in Southern Highlands Zone, Tanzania (N=309) Chi square.

Variable	Quality of Life		P value
	Low; n (%)	High; n (%)
HIV status disclosure:
No	102 (49.3)	105 (50.7)	<0.001
Yes	25 (24.5)	77 (75.5)
Child/caregiver relationship:
Biological parents	87 (46.0)	102 (54.0)	<0.05
Others	40 (33.3)	80 (66.7)
Sex of the child:
Males	69 (44.8)	85 (55.2)	0.187
Females	58 (37.4)	97 (62.60
Age of the child:
6 to 9 years	30 (55.6)	24 (44.4)	<0.05
10 to 13 years	54 (40.0)	81 (60.0)
14 to 17 years	43 (35.8)	77 (64.2)
ART adherence:	10 (47.6)	11(52.4)	0.529
No	117 (40.6)	171(59.4)
Yes
Caregiver income
Employment	40 (44.4)	50 (55.6)
Others	87 (39.7)	132 (60.3)	0.444
Child’s level of education:
Primary or less	99 (41.6)	139 (58.4)	0.745
Secondary or high	28 (39.4)	43 (60.6)
Caregiver level of education:
Primary or less	87 (39.5)	133 (60.5)	0.382
Secondary or high	40 (44.9)	49 (55.1)